$155.86
1.180.76%
At close: -
$155.86
0.000.00%
After Hours: 4:02 PM EDT
Comments
Loading...
Ascendis Pharma Earnings Estimates, EPS & Revenue | NASDAQ:ASND | Benzinga
Ascendis Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS Estimate
$-1.350
Quarterly Revenue Estimate
$88.54M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$363.64M
Analyze the earnings history of Ascendis Pharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma | -$2.50 | -$1.35 | — | — | $104.15M | $88.54M | — | — | 05/01/2025 | Get Alert |
| ASND | Ascendis Pharma | -$1.66 | -$1.20 | -$0.68 | 43.33% | $148.22M | $122.54M | $185.62M | 51.48% | 02/12/2025 | Get Alert |
| ASND | Ascendis Pharma | -$3.13 | -$1.52 | -$1.89 | -24.34% | $52.28M | $70.31M | $63.56M | -9.59% | 11/14/2024 | Get Alert |
| ASND | Ascendis Pharma | -$2.35 | -$1.56 | -$2.06 | -32.05% | $51.66M | $92.74M | $38.76M | -58.21% | 09/03/2024 | Get Alert |
| ASND | Ascendis Pharma | -$2.13 | — | -$2.50 | — | $36.05M | — | $104.15M | — | 05/02/2024 | Get Alert |
| ASND | Ascendis Pharma | -$3.78 | -$2.15 | -$1.66 | 22.79% | $23.37M | $97.02M | $148.22M | 52.77% | 02/07/2024 | Get Alert |
| ASND | Ascendis Pharma | -$3.05 | -$2.75 | -$3.13 | -13.82% | $15.41M | $52.70M | $52.28M | -0.79% | 11/07/2023 | Get Alert |
| ASND | Ascendis Pharma | -$1.56 | -$2.68 | -$2.35 | 1231.34% | $6.57M | $41.73M | $51.66M | 2378.38% | 09/05/2023 | Get Alert |
| ASND | Ascendis Pharma | -$2.48 | — | -$2.13 | — | $7.67M | — | $36.05M | — | 04/27/2023 | Get Alert |
| ASND | Ascendis Pharma | -$2.14 | — | -$3.78 | — | $5.60M | — | $23.37M | — | 02/16/2023 | Get Alert |
| ASND | Ascendis Pharma | -$1.73 | -$2.48 | -$3.05 | -22.98% | $1.31M | — | $15.41M | — | 11/02/2022 | Get Alert |
| ASND | Ascendis Pharma | -$3.01 | -$2.17 | -$1.56 | 28.11% | $1.23M | $5.92M | $6.57M | 10.90% | 08/10/2022 | Get Alert |
| ASND | Ascendis Pharma | -$1.41 | — | -$2.48 | — | $899.60K | — | $7.67M | — | 05/11/2022 | Get Alert |
| ASND | Ascendis Pharma | -$3.15 | -$2.63 | -$2.14 | 18.63% | $637.88K | $2.98M | $5.60M | 87.95% | 03/02/2022 | Get Alert |
| ASND | Ascendis Pharma | -$2.70 | — | -$1.73 | — | $3.22B | — | $1.31M | — | 11/10/2021 | Get Alert |
| ASND | Ascendis Pharma | -$2.17 | -$2.75 | -$3.01 | -9.45% | $1.58M | $1.46M | $1.23M | -15.68% | 08/25/2021 | Get Alert |
| ASND | Ascendis Pharma | -$1.46 | -$2.08 | -$1.41 | 32.21% | $2.45M | $2.30M | $899.60K | -60.89% | 05/27/2021 | Get Alert |
| ASND | Ascendis Pharma | -$1.89 | -$1.83 | -$3.15 | -72.13% | $2.78M | $1.99M | $637.88K | -67.95% | 03/10/2021 | Get Alert |
| ASND | Ascendis Pharma | -$0.58 | -$1.86 | -$2.70 | -45.16% | $2.24M | $1.66M | $3.22M | 94.10% | 11/11/2020 | Get Alert |
| ASND | Ascendis Pharma | -$1.39 | -$1.70 | -$2.17 | -27.65% | $3.56M | $2.53M | $1.58M | -37.51% | 08/27/2020 | Get Alert |
| ASND | Ascendis Pharma | -$1.38 | -$1.50 | -$1.46 | 2.67% | $6.01M | $2.07M | $2.45M | 18.55% | 05/19/2020 | Get Alert |
| ASND | Ascendis Pharma | -$0.85 | -$1.19 | -$1.89 | -58.82% | $11.78M | $1.25M | $2.78M | 122.64% | 04/01/2020 | Get Alert |
Ascendis Pharma (ASND) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-12 | $-0.68 | $-1.20 | 43.3 % |
| Q3 | 2024-11-14 | $-1.89 | $-1.52 | -24.3 % |
| Q2 | 2024-09-03 | $-2.06 | $-1.56 | -32.0 % |
| Q4 | 2024-02-07 | $-1.66 | $-2.15 | 22.8 % |
Ascendis Pharma (ASND) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-12 | $185.62M | $122.54M | 51.5 % |
| Q3 | 2024-11-14 | $63.57M | $70.31M | -9.59 % |
| Q2 | 2024-09-03 | $38.76M | $92.74M | -58.2 % |
| Q4 | 2024-02-07 | $148.22M | $97.02M | 52.8 % |
FAQ
When is Ascendis Pharma (NASDAQ:ASND) reporting earnings?
Ascendis Pharma (ASND) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on February 12, 2025 for Q4.
What were the latest earnings per share (EPS) for Ascendis Pharma (NASDAQ:ASND)?
The Actual EPS was $-0.68, which beat the estimate of $-1.20.
What were Ascendis Pharma’s (NASDAQ:ASND) revenues?
The Actual Revenue was $185.6M, which beat the estimate of $122.5M.
Browse earnings estimates, EPS, and revenue on all stocks.